Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group -
Metronomic chemotherapy in breast cancer | Semantic Scholar
Frontiers | Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
Different mechanisms of action of a metronomic chemotherapy. (modified... | Download Scientific Diagram
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? - ScienceDirect
Cover Image: Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center - Lu - 2020 - Cancer Communications - Wiley Online Library
Low Dose / Metronomic Chemotherapy | Lifespring Cancer Treatment Center
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project | SpringerLink
Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
UCD Conway Institute of Biomolecular and Biomedical Research | Metronomic chemotherapy shows therapeutic benefits in preclinical models of cancer
Metronomic chemotherapy in non‑small cell lung cancer (Review)
Metronomic chemotherapy in mbc | PPT
Low Dose Metronomic Chemotherapy for Breast Cancer | Ultimate in Integrative Holistic Cancer Therapy, Houston, Texas
Pharmaceutics | Free Full-Text | Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice - ScienceDirect
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
Metronomic Chemotherapy in Breast Cancers | SpringerLink
A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol – topic
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer,Thoracic Cancer - X-MOL
Metronomic Chemotherapy for Triple-Negative Breast Cancer
Metronomic chemotherapy: new rationale for new directions | Nature Reviews Clinical Oncology
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers | EMBO Molecular Medicine
JCM | Free Full-Text | Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
Metronomic chemotherapy for advanced breast cancer patients
Achievements and challenges in the use of metronomics for the treatment of breast cancer - ScienceDirect
